Network-based approach reveals Y chromosome influences prostate cancer susceptibility

Computers in Biology and Medicine

Volumn 54, Issue , 2014, Pages 24-31

  Khosravi, Pegah ^a   Gazestani, Vahid H ^b   Asgari, Yazdan ^c   Law, Brian ^d,e   Sadeghi, Mehdi ^f,g   Goliaei, Bahram ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b MCGILL UNIVERSITY   (Canada)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^g INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

Author keywords

Co expression networks; Expression data; Prostate cancer; Reverse engineering approach; Y chromosome genes

Indexed keywords

CO-EXPRESSION NETWORKS; EXPRESSION DATA; NETWORK-BASED APPROACH; PROSTATE CANCERS; Y CHROMOSOMES;

ACCURACY; ARTICLE; CANCER SUSCEPTIBILITY; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; PROSTATE CANCER; REVERSE ENGINEERING; Y CHROMOSOME; BIOLOGICAL MODEL; COMPUTER SIMULATION; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; MALE; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TUMOR GENE;

TUMOR PROTEIN;

CHROMOSOMES, HUMAN, Y; COMPUTER SIMULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MODELS, GENETIC; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84908509275     PISSN: 00104825     EISSN: 18790534     Source Type: Journal    
DOI: 10.1016/j.compbiomed.2014.08.020     Document Type: Article

References (44)

1. Vogelstein B., Kinzler K.W. Cancer genes and the pathways they control. Nat. Med. 2004, 10:789-799.
2. Witte J.S. Prostate cancer genomics: towards a new understanding. Nat. Rev. Genet. 2009, 10:77-82.
3. Faith J.J., Hayete B., Thaden J.T., Mogno I., Wierzbowski J., Cottarel G., Kasif S., Collins J.J., Gardner T.S. Large-scale mapping and validation of Escherichia coli transcriptional regulation from a compendium of expression profiles. PLoS Biol. 2007, 5:e8.
4. Margolin A.A., Nemenman I., Basso K., Wiggins C., Stolovitzky G., Dalla Favera R., Califano A. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinf. 2006, 7(Suppl. 1):S7.
5. Butte A.J., Kohane I.S. Mutual information relevance networks: functional genomic clustering using pairwise entropy measurements. Pac. Symp. Biocomput. 2000, 418-429.
6. Hecker M., Lambeck S., Toepfer S., van Someren E., Guthke R. Gene regulatory network inference: data integration in dynamic models-a review. BioSystems 2009, 96:86-103.
7. Hornberg J.J., Bruggeman F.J., Westerhoff H.V., Lankelma J. Cancer: a systems biology disease. BioSystems 2006, 83:81-90.
8. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J. Clin. 2013, 63:11-30.
9. Mazaris E., Tsiotras A. Molecular pathways in prostate cancer. Nephro-Urol. Mon. 2013, 5:792-800.
10. Jangravi Z., Alikhani M., Arefnezhad B., Sharifi Tabar M., Taleahmad S., Karamzadeh R., Jadaliha M., Mousavi S.A., Ahmadi Rastegar D., Parsamatin P., Vakilian H., Mirshahvaladi S., Sabbaghian M., Mohseni Meybodi A., Mirzaei M., Shahhoseini M., Ebrahimi M., Piryaei A., Moosavi-Movahedi A.A., Haynes P.A., Goodchild A.K., Nasr-Esfahani M.H., Jabbari E., Baharvand H., Sedighi Gilani M.A., Gourabi H., Salekdeh G.H. A fresh look at the male-specific region of the human Y chromosome. J. Proteome Res. 2013, 12:6-22.
11. Friedman N. Inferring cellular networks using probabilistic graphical models. Science 2004, 303:799-805.
12. Schafer J., Strimmer K. An empirical Bayes approach to inferring large-scale gene association networks. Bioinformatics 2005, 21:754-764.
13. Butte A.J., Tamayo P., Slonim D., Golub T.R., Kohane I.S. Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. Proc. Nat. Acad. Sci. U.S.A. 2000, 97:12182-12186.
14. Basso K., Margolin A.A., Stolovitzky G., Klein U., Dalla-Favera R., Califano A. Reverse engineering of regulatory networks in human B cells. Nat. Genet. 2005, 37:382-390.
15. Marbach D., Costello J.C., Kuffner R., Vega N.M., Prill R.J., Camacho D.M., Allison K.R., Consortium D., Kellis M., Collins J.J., Stolovitzky G. Wisdom of crowds for robust gene network inference. Nat. Methods 2012, 9:796-804.
16. Hoffmann R., Valencia A. A gene network for navigating the literature. Nat. Genet. 2004, 36:664.
17. Chandran U.R., Ma C., Dhir R., Bisceglia M., Lyons-Weiler M., Liang W., Michalopoulos G., Becich M., Monzon F.A. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 2007, 7:64.
18. Masseroli M., Pinciroli F. Using gene ontology and genomic controlled vocabularies to analyze high-throughput gene lists: three tool comparison. Comput. Biol. Med. 2006, 36:731-747.
19. Oz-Levi D., Ben-Zeev B., Ruzzo E.K., Hitomi Y., Gelman A., Pelak K., Anikster Y., Reznik-Wolf H., Bar-Joseph I., Olender T., Alkelai A., Weiss M., Ben-Asher E., Ge D., Shianna K.V., Elazar Z., Goldstein D.B., Pras E., Lancet D. Mutation in TECPR2 reveals a role for autophagy in hereditary spastic paraparesis. Am. J. Hum. Genet. 2012, 91:1065-1072.
20. Bogoyevitch M.A., Glennon P.E., Andersson M.B., Clerk A., Lazou A., Marshall C.J., Parker P.J., Sugden P.H. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J. Biol. Chem. 1994, 269:1110-1119.
21. Freeman L.C. Set of measures of centrality based on betweenness. Sociometry 1977, 40:35-41.
22. Girvan M., Newman M.E.J. Community structure in social and biological networks. Proc. Nat. Acad. Sci. U.S.A. 2002, 99:7821-7826.
23. Yu H.Y., Kim P.M., Sprecher E., Trifonov V., Gerstein M. The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput. Biol. 2007, 3:713-720.
24. Zahiri J., Bozorgmehr J.H., Masoudi-Nejad A. Computational prediction of protein-protein interaction networks: algo-rithms and resources. Curr. Genomics 2013, 14:397-414.
25. Pitre S., Alamgir M., Green J.R., Dumontier M., Dehne F., Golshani A. Computational methods for predicting protein-protein interactions. Adv. Biochem. Eng. Biotechnol. 2008, 110:247-267.
26. Lin C.Y., Chin C.H., Wu H.H., Chen S.H., Ho C.W., Ko M.T. Hubba: hub objects analyzer-a framework of interactome hubs identification for network biology. Nucleic Acids Res. 2008, 36:W438-W443.
27. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13:2498-2504.
28. Reimand J., Bader G.D. Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers. Mol. Syst. Biol. 2013, 9:637.
29. Ergun A., Lawrence C.A., Kohanski M.A., Brennan T.A., Collins J.J. A network biology approach to prostate cancer. Mol. Syst. Biol. 2007, 3.
30. Kanehisa M., Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28:27-30.
31. Kanehisa M., Goto S., Sato Y., Kawashima M., Furumichi M., Tanabe M. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 2014, 42:D199-D205.
32. Luscombe N.M., Babu M.M., Yu H., Snyder M., Teichmann S.A., Gerstein M. Genomic analysis of regulatory network dynamics reveals large topological changes. Nature 2004, 431:308-312.
33. Huang S., Ingber D.E. A non-genetic basis for cancer progression and metastasis: self-organizing attractors in cell regulatory networks. Breast Dis. 2006, 26:27-54.
34. Denmeade S.R., Lin X.S., Isaacs J.T. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate 1996, 28:251-265.
35. Kang H.Y., Lin H.K., Hu Y.C., Yeh S., Huang K.E., Chang C. From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells. Proc. Nat. Acad. Sci. U.S.A. 2001, 98:3018-3023.
36. Goodarzi H., Elemento O., Tavazoie S. Revealing global regulatory perturbations across human cancers. Mol. Cell. 2009, 36:900-911.
37. Ren S., Peng Z., Mao J.H., Yu Y., Yin C., Gao X., Cui Z., Zhang J., Yi K., Xu W., Chen C., Wang F., Guo X., Lu J., Yang J., Wei M., Tian Z., Guan Y., Tang L., Xu C., Wang L., Gao X., Tian W., Wang J., Yang H., Wang J., Sun Y. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell. Res. 2012, 22:806-821.
38. Perner S. Dangerous liaisons in prostate cancer. Clinical and biological implications of recurrent gene fusions. Der Pathol. 2010, 31(Suppl. 2):121-125.
39. Perinchery G., Sasaki M., Angan A., Kumar V., Carroll P., Dahiya R. Deletion of Y-chromosome specific genes in human prostate cancer. J. Urol. 2000, 163:1339-1342.
40. Dasari V.K., Goharderakhshan R.Z., Perinchery G., Li L.C., Tanaka Y., Alonzo J., Dahiya R. Expression analysis of Y chromosome genes in human prostate cancer. J. Urol. 2001, 165:1335-1341.
41. Lau Y.F. Gonadoblastoma, testicular and prostate cancers, and the TSPY gene. Am. J. Hum. Genet. 1999, 64:921-927.
42. Thompson V.C., Hurtado-Coll A., Turbin D., Fazli L., Lehman M.L., Gleave M.E., Nelson C.C. Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer. Prostate 2010, 70:1134-1145.
43. Descazeaud A., Rubin M.A., Hofer M., Setlur S., Nikolaief N., Vacherot F., Soyeux P., Kheuang L., Abbou C.C., Allory Y., de la Taille A. BPH gene expression profile associated to prostate gland volume. Diagn. Mol. Pathol.: 2008, 17:207-213.
44. Lau Y.F., Zhang J. Expression analysis of thirty one Y chromosome genes in human prostate cancer. Mol. Carcinog. 2000, 27:308-321.